LOC631145, or FAM90A1B (family with sequence similarity 90, member A1B) Activators encompass a diverse array of chemical compounds that indirectly augment the functional activity of FAM90A1B through various signaling pathways and epigenetic mechanisms. Resveratrol, by influencing the SIRT1 signaling pathway, indirectly leads to the enhanced activity of FAM90A1B by modulating gene expression. Similarly, Curcumin, through its action on the NF-kB pathway, indirectly upregulates FAM90A1B by reducing the transcription of genes that negatively regulate pathways in which FAM90A1B is involved. Epigenetic modulators like Epigallocatechin Gallate (EGCG), Sodium Butyrate, Trichostatin A, and 5-Azacytidine, through their respective mechanisms of inhibiting DNA methyltransferases and histone deacetylases, contribute to the upregulation of FAM90A1B expression by altering the chromatin structure and DNA methylation patterns, enhancing the accessibility of its promoter region for transcription. Retinoic Acid and Vitamin D3 further influence FAM90A1B activity by regulating gene expression through their respective receptors, potentially upregulating FAM90A1B in the process.
The modulation of FAM90A1B activity is also influenced by compounds that affect intracellular signaling pathways and cellular metabolic states. Lithium Chloride, by impacting the Wnt signaling pathway, potentially enhances FAM90A1B expression by modulating β-catenin levels and TCF/LEF-mediated transcription. Rapamycin, an inhibitor of the mTOR pathway, alters gene expression patterns, which could lead to the upregulation of FAM90A1B by changing the cellular metabolic environment. Forskolin, through the activation of adenylate cyclase and the subsequent increase in cAMP levels, influences PKA activity, potentially leading to the upregulation of FAM90A1B by phosphorylating transcription factors involved in its expression. Dexamethasone, acting through the glucocorticoid receptor, further regulates gene expression, potentially enhancing FAM90A1B activity by modulating transcription factors that affect its transcription. Collectively, these FAM90A1B Activators, through their targeted effects on cellular signaling and epigenetic regulation, facilitate the enhancement of FAM90A1B-mediated functions, highlighting the complexity and integration of various biochemical pathways in regulating protein activity.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Influences the SIRT1 signaling pathway, indirectly leading to the enhanced activity of FAM90A1B by modulating gene expression. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Acts on the NF-kB pathway, potentially leading to an indirect enhancement of FAM90A1B expression by reducing transcription of genes negatively regulated by NF-kB. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Inhibits DNA methyltransferases, leading to hypomethylation and potentially enhancing FAM90A1B expression by making its promoter region more accessible. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Histone deacetylase inhibitor, increasing histone acetylation and potentially enhancing FAM90A1B expression by allowing greater transcriptional access. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Another histone deacetylase inhibitor, promoting histone acetylation and potentially leading to upregulation of FAM90A1B expression. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
DNA methyltransferase inhibitor, decreases DNA methylation levels which can lead to increased expression of FAM90A1B. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Regulates gene expression through retinoic acid receptors, which can indirectly enhance FAM90A1B expression. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Influences the Wnt signaling pathway by inhibiting GSK-3β, potentially enhancing FAM90A1B expression through β-catenin and TCF/LEF-mediated transcription. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Inhibits the mTOR pathway, potentially upregulating FAM90A1B expression by altering cellular metabolic states. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Acts through the glucocorticoid receptor to regulate gene expression, potentially enhancing FAM90A1B expression. | ||||||